Business Context and Reporting Period
This Form 6-K filing by IM Cannabis Corp. covers the month of September 2026, specifically reporting on a financing transaction closed on September 2, 2026. The Company, headquartered in Kibbutz Glil Yam, Israel, operates in the medical cannabis sector with a focus on the Israel and Germany markets.
Key Financial Metrics
The filing details a specific capital raise rather than periodic financial performance metrics such as revenue or operating profit.
- Gross Proceeds: US$225,000 raised via a convertible note.
- Net Proceeds: US$202,500 intended for general corporate purposes.
- Debt Instrument: Convertible Note with an 8.0% annual interest rate (increasing to 14.0% upon an Event of Default).
- Repayment Terms: The Note is not repayable in cash; obligations are satisfied solely through the issuance of Common Shares upon conversion.
- Warrant Issuance: Warrant to purchase up to 77,855 Common Shares at an exercise price of CAD$4.63 per share.
Material Changes
The primary material change is the execution of a Note Purchase Agreement with an institutional investor. This transaction introduces new debt obligations that are structured to convert into equity, potentially diluting existing shareholders. The filing does not provide comparative financial data (e.g., revenue or profit changes) against prior periods as it is a transaction-specific report.
Guidance, Outlook, and Risks
Management Commentary and Use of Proceeds: Management intends to use the net proceeds for general corporate purposes. The Company has agreed to file a resale registration statement on Form F-3 within 30 trading days of the closing date.
Risks and Contingencies: The filing includes extensive forward-looking statement disclaimers highlighting significant risks, including:
- Regulatory compliance in highly regulated jurisdictions.
- Impact of geopolitical conflicts, specifically the multi-front war in Israel, on operations and the industry.
- Reliance on third-party supply agreements and key personnel.
- Ability to maintain Nasdaq Capital Market listing requirements.
- Uncertainty regarding sustainable profitability and cost management.
Investor Verification Checklist
- Verify the effective date of the Form F-3 resale registration statement to confirm the timeline for investor liquidity.
- Review the specific definitions of "Fixed Price" (US$3.328) and "Floor Price" (US$0.665692) in the attached Convertible Note to assess potential dilution scenarios.
- Confirm the Company's current cash position and runway given the reliance on convertible debt rather than cash repayment.
- Monitor geopolitical developments in Israel and their specific impact on the Company's production and export capabilities.
- Check for any subsequent filings regarding the status of the 4-month trading lock-up period for the Warrant Shares.